Dr. Marc-andre Cornier, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
12605 E 16th Ave
Aurora, CO 80045
Who else practices at this address →
Adams County includes primary care (2% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Medical College of Georgia School of Medicine (1992)
- Years since graduation
- 34
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 92
Licensed in Colorado since 1996, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1992Medical school: Medical College of Georgia School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
CO license 35310 (first issued 1996; expired)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Musc Medical Center Charleston, SC
- Tidelands Waccamaw Community Hospital Murrells Inlet, SC
Medical groups
- University Medical Associates of the Medical University of South Carol (1,668 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 92
- Services billed
- 286
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 81 | 63 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 38 | 21 |
| Established patient office or other outpatient visit, 40-54 minutes | 17 | 15 |
| New patient office or other outpatient visit, 45-59 minutes | 16 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Mounjaro (tirzepatide) Other prescribers in Aurora, CO | 116 |
| Repatha Sureclick (evolocumab) Other prescribers in Aurora, CO | 103 |
| Rosuvastatin Calcium Other prescribers in Aurora, CO | 65 |
| Ozempic (semaglutide) Other prescribers in Aurora, CO | 60 |
| Ezetimibe Other prescribers in Aurora, CO | 58 |
| Jardiance (empagliflozin) Other prescribers in Aurora, CO | 53 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in Aurora, CO | 47 |
| Metformin Hcl Er (metformin hcl) Other prescribers in Aurora, CO | 33 |
| Levothyroxine Sodium Other prescribers in Aurora, CO | 28 |
| Praluent Pen (alirocumab) Other prescribers in Aurora, CO | 27 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 31 payments worth $31,262 in total to this clinician.
| Eli Lilly and Company | $21,905 |
|---|---|
| Novo Nordisk Inc | $8,003 |
| AstraZeneca Pharmaceuticals LP | $1,074 |
| Madrigal Pharmaceuticals | $139 |
| Corcept Therapeutics | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.15 |
| Consulting Fee | $28,125 |
|---|---|
| Travel and Lodging | $2,001 |
| Food and Beverage | $1,136 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Eli Lilly and Company Apr 21, 2025 | Consulting Fee ZEPBOUND · Obesity | $9,700 |
| Novo Nordisk Inc Aug 11, 2025 | Consulting Fee Ozempic · Diabetes | $6,626 |
| Eli Lilly and Company May 21, 2025 | Consulting Fee | $4,950 |
| Eli Lilly and Company Nov 20, 2025 | Consulting Fee | $1,925 |
| Eli Lilly and Company Nov 20, 2025 | Consulting Fee | $1,925 |
| Eli Lilly and Company May 21, 2025 | Consulting Fee | $1,925 |
| AstraZeneca Pharmaceuticals LP Feb 6, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $1,074 |
| Novo Nordisk Inc Aug 11, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Plainsboro, NJ · in-kind | $497 |
| Eli Lilly and Company May 3, 2025 | Travel and Lodging travel to CHICAGO, SC · in-kind | $462 |
| Novo Nordisk Inc Aug 11, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Plainsboro, NJ · in-kind | $262 |
All 17 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Eli Lilly and Company Nov 20, 2025 | Consulting Fee | $1,925 |
| Eli Lilly and Company Nov 20, 2025 | Consulting Fee | $1,925 |
| Novo Nordisk Inc Aug 11, 2025 | Consulting Fee Ozempic · Diabetes | $6,626 |
| Novo Nordisk Inc Aug 11, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Plainsboro, NJ · in-kind | $497 |
| Novo Nordisk Inc Aug 11, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Plainsboro, NJ · in-kind | $262 |
| Novo Nordisk Inc Aug 11, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Plainsboro, NJ · in-kind | $217 |
| Novo Nordisk Inc Aug 11, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Plainsboro, NJ · in-kind | $33.40 |
| Eli Lilly and Company May 21, 2025 | Consulting Fee | $4,950 |
| Eli Lilly and Company May 21, 2025 | Consulting Fee | $1,925 |
| Eli Lilly and Company May 21, 2025 | Travel and Lodging travel to ROSEMONT, IL | $60.00 |
| Eli Lilly and Company May 21, 2025 | Travel and Lodging travel to ROSEMONT, IL | $4.00 |
| Eli Lilly and Company May 3, 2025 | Travel and Lodging travel to CHICAGO, SC · in-kind | $462 |
| Eli Lilly and Company May 3, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionLODGING EXPENSES RELATED TO A MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $181 |
| Eli Lilly and Company May 3, 2025 | Travel and Lodging travel to CHICAGO, IL · in-kind Company’s descriptionGROUND TRANSPORTATION EXPENSES FOR A MEETING WHICH MAY HAVE LASTED MULTIPLE DAYS | $175 |
| Eli Lilly and Company Apr 21, 2025 | Consulting Fee ZEPBOUND · Obesity | $9,700 |
| Eli Lilly and Company Apr 10, 2025 | Travel and Lodging travel to FRANKFURT, Germany · in-kind | $109 |
| AstraZeneca Pharmaceuticals LP Feb 6, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $1,074 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 3 companies. The companies reported $187,653 in research payments for these studies, mostly to the institutions running them.
- TRANSFORM
Cleerly, Inc. - Study name not reported
Ionis Pharmaceuticals, Inc. - Study name not reported
Ionis Pharmaceuticals, Inc. - Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT)
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.